Market Overview: The autoimmune hepatitis market reached a value of US$ 115.3 Million in 2023 and expected to reach US$ 156.9 Million by 2034, exhibiting a growth rate (CAGR) of 2.84% during 2024-2034. The autoimmune hepatitis market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It...